Insulet Corporation (PODD) PT Lowered to $180 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise by about $1/bbl on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
Insulet (PODD) shares jump after raising full-year revenue growth guidance
November 3, 2023 8:34 AM EDTInsulet (NASDAQ: PODD) shares jumped more than 9% Friday, boosted by the company's latest earnings release, which topped consensus expectations.
The medical device company reported Q3 EPS of $0.74, $0.34 better than the analyst estimate of $0.40, while revenue for the quarter came in at $432.7 million, up 27%... More
